Clinical trial
Single-centre Study Exploring the Utility of Hyperpolarized 129Xe Magnetic Resonance Imaging in Healthy Volunteers and Patients With Lung Disease
NCT03455686 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single-centre Study Exploring the Utility of Hyperpolarized 129Xe Magnetic Resonance Imaging in Healthy Volunteers and Patients With Lung Disease
- Lead sponsor
- McMaster University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 19, 2018
- Completion date
- December 31, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alpha 1-antitrypsin deficiency, asthma, bronchiectasis, bronchopulmonary dysplasia, chronic obstructive pulmonary disease, emphysema, pulmonary fibrosis, sarcoidosis, pulmonary